Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
August 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
Press releases published on May 2, 2025
Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
GlobeNewswire
·
May 2, 2025
VAMOS analysis highlights link between EVAF and reduced muscle quality Case series reports success with combination tesamorelin/GLP-1 receptor agonist therapy MONTREAL, May 02, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “ …
Theratechnologies présente à la conférence ACTHIV 2025 de nouvelles données soulignant l’importance de prendre en charge l’excès de graisse viscérale abdominale chez les personnes vivant avec le VIH
GlobeNewswire
·
May 2, 2025
L’analyse réalisée dans le cadre de l’étude VAMOS met en évidence le lien entre l’excès de graisse viscérale abdominale et la diminution de la qualité musculaire Selon ce qu’on rapporte dans la série de cas, l’association de la tésamoréline à un agoniste …
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on May 1, …
Cartesian Therapeutics Announces New Employment Inducement Grants
GlobeNewswire
·
May 2, 2025
FREDERICK, Md., May 02, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for the treatment of autoimmune diseases, today announced the granting of …
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
RESEARCH TRIANGLE PARK, N.C., May 02, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted seven newly-hired employees restricted stock units (RSUs) …
Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025
GlobeNewswire
·
May 2, 2025
CAMBRIDGE, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the …
Metagenomi to Present at Upcoming Scientific Meetings
GlobeNewswire
·
May 2, 2025
EMERYVILLE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today announced that the …
Best Email Service For Business (2025): Klaviyo Awarded Top Email Marketing Software by Software Experts
GlobeNewswire
·
May 2, 2025
NEW YORK CITY, May 02, 2025 (GLOBE NEWSWIRE) -- Software Experts has named Klaviyo one of the top email marketing platforms of the year. Klaviyo’s AI-powered automation, real-time customer data integration, and multi-channel marketing capabilities position …
Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration
GlobeNewswire
·
May 2, 2025
Clinical trial of KH658 evaluates single suprachoroidal space administration of gene-therapy treatment for wet AMD CHENGDU, China and ROCKAWAY, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- Chengdu Origen Biotechnology Co., Ltd. (“Chengdu Origen”) and Vanotech …
Orion Corporation: Managers’ transactions – Veli-Matti Mattila
GlobeNewswire
·
May 2, 2025
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Veli-Matti Mattila Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …
Orion Oyj: Johtohenkilöiden liiketoimet – Veli-Matti Mattila
GlobeNewswire
·
May 2, 2025
ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Veli-Matti Mattila Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …
Orion Corporation: Managers’ transactions – Hilpi Rautelin
GlobeNewswire
·
May 2, 2025
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Hilpi Rautelin Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …
Orion Oyj: Johtohenkilöiden liiketoimet – Hilpi Rautelin
GlobeNewswire
·
May 2, 2025
ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Hilpi Rautelin Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …
Orion Corporation: Managers’ transactions – Kari Jussi Aho
GlobeNewswire
·
May 2, 2025
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Kari Jussi Aho Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …
Orion Oyj: Johtohenkilöiden liiketoimet – Kari Jussi Aho
GlobeNewswire
·
May 2, 2025
ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Kari Jussi Aho Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …
Orion Corporation: Managers’ transactions – Maziar Mike Doustdar
GlobeNewswire
·
May 2, 2025
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Maziar Mike Doustdar Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …
Orion Oyj: Johtohenkilöiden liiketoimet – Maziar Mike Doustdar
GlobeNewswire
·
May 2, 2025
ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Maziar Mike Doustdar Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …
Orion Corporation: Managers’ transactions – Ari Lehtoranta
GlobeNewswire
·
May 2, 2025
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Ari Lehtoranta Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …
Orion Oyj: Johtohenkilöiden liiketoimet – Ari Lehtoranta
GlobeNewswire
·
May 2, 2025
ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Ari Lehtoranta Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …
Orion Corporation: Managers’ transactions – Eija Ronkainen
GlobeNewswire
·
May 2, 2025
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Eija Ronkainen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …